U.S. approves Johnson & Johnson’s singe-shot COVID-19 vaccine
The U.S. has authorized Johnson & Johnson's single-dose COVID-19 vaccine for emergency use. As Jennifer Johnson reports, the approval follows a rise in COVID-19 cases linked to new variants.
UP NEXT
UP NEXT
-
Ontario’s new COVID-19 restrictions include increased police powers
Global News
-
Science experts question new provincial rules in Ontario, lack of paid sick leave
Global News
-
Stay-at-home order is failing to reduce transmission in Peterborough area
Global News
-
Canada to receive 2.8 million Moderna COVID-19 vaccine doses in May, officials address delays
Global News
-
Trudeau defends his government’s COVID-19 vaccine rollout following comparison to U.S.
Global News
-
Tenant rescued from Peterborough townhouse fire
Global News
-
Non-essential retail must close in-person shopping under new Ontario restrictions
Global News
-
Ontario sees highest COVID-19 case numbers since mid-January
Global News
-
Toronto Mayor Tory says Canada Recovery Sickness Benefit needs to be examined by officials
Global News
-
CSIS staff concerned about workplace safety during pandemic
Global News
-
Rollover on off-ramp on Highway 7/115 in Peterborough
Global News
-
Ford says high-risk essential workers get priority as Ontario’s Phase 2 COVID-19 vaccine rollout begins
Global News
-
Fact or Fiction: Are news reporters straying from the ethics and guidelines of journalism?
Global News
-
'Fake News' explained: How disinformation spreads
-
Online game helps people detect fake news
Global News
-
Colborne sudden death now being investigated as homicide: OPP
Global News